# FDA Inspection 1196323 - Glaxo Operations UK Ltd. - September 01, 2022

Source: https://www.keypedia.com/records/fda_inspections/glaxo-operations-uk-ltd/3e06641c-33a0-429f-abbc-3ed107266eaa
Source feed: FDA_Inspections

> FDA Inspection 1196323 for Glaxo Operations UK Ltd. on September 01, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1196323
- Company Name: Glaxo Operations UK Ltd.
- Inspection Date: 2022-09-01
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 984369 - 2016-06-10](https://www.keypedia.com/records/fda_inspections/glaxo-operations-uk-ltd/e013666b-587d-47c0-a3e7-13e5dd5e2f10)
- [FDA Inspection 842646 - 2013-05-31](https://www.keypedia.com/records/fda_inspections/glaxo-operations-uk-ltd/a5b2d247-ab96-4de2-a60d-763b950b771e)
- [FDA Inspection 641543 - 2009-12-14](https://www.keypedia.com/records/fda_inspections/glaxo-operations-uk-ltd/cc089861-6291-4536-b8ca-aa0e28e07b9d)

Company: https://www.keypedia.com/companies/glaxo-operations-uk-ltd/1eca8372-d80f-449f-a11b-4303ce0d0856

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c